Joint Clinical Trials Office

You are here

ROMA Trial

Clinical Trial Details

The purpose of this study is to determine the effect of single vs. multiple arterial revascularization (this is the restoration of blood flow to an organ) for patients undergoing coronary artery bypass surgery. 

The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, post discharge myocardial infarction and/or repeat revascularization. The secondary hypothesis is that in patients undergoing primary isolated non-emergent CABG, the use of two or more arterial grafts compared to a single arterial graft is associated with improved survival. 

Key Eligibility: 

Patients who will undergo surgery for primary isolated CABG with disease of the left main coronary artery or of the left anterior descending and the circumflex coronary system with or without disease of the right coronary artery. 

 

Contact

Renee Aviv
Rek9015@med.cornell.edu
(212) 746-5194

Primary Investigator

Mario Gaudino M.D.

Protocol ID(s)

Weill Cornell Medicine IRB #:

1703018094

ClinicalTrials.gov:

NCT03217006

Status:

Open to Enrollment

Age Group

Adult

Study Type

Phase